Patents by Inventor Isabelle Nardin

Isabelle Nardin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10857127
    Abstract: The present disclosure provides pharmaceutical compositions that include one or more selective estrogen receptor modulator(s) (SERM(s), e.g., Lasofoxifene) and four or more pharmaceutically acceptable excipients. The pharmaceutical compositions may be able to form nanodroplets (e.g., by self-nanoemulsifying) in vaginal fluid and to deliver the one or more SERM(s) to the vagina of a female subject. The pharmaceutical compositions may be useful in treating or preventing vulvovaginal atrophy, dyspareunia, sexual dysfunction, osteoporosis, or breast cancer in a female subject.
    Type: Grant
    Filed: May 19, 2017
    Date of Patent: December 8, 2020
    Assignee: Azure Biotech, Inc.
    Inventors: Valerie Ceva, Steven R. Goldstein, Susan L. Levinson, David D. Thompson, Andreas Bernkop-Schnürch, Isabelle Nardin
  • Publication number: 20170333394
    Abstract: The present disclosure provides pharmaceutical compositions that include one or more selective estrogen receptor modulator(s) (SERM(s), e.g., Lasofoxifene) and four or more pharmaceutically acceptable excipients. The pharmaceutical compositions may be able to form nanodroplets (e.g., by self-nanoemulsifying) in vaginal fluid and to deliver the one or more SERM(s) to the vagina of a female subject. The pharmaceutical compositions may be useful in treating or preventing vulvovaginal atrophy, dyspareunia, sexual dysfunction, osteoporosis, or breast cancer in a female subject.
    Type: Application
    Filed: May 19, 2017
    Publication date: November 23, 2017
    Inventors: Valerie Ceva, Steven R. Goldstein, Susan L. Levinson, David D. Thompson, Andreas Bernkop-Schnürch, Isabelle Nardin